Ultimate Healing Peptide Stack: BPC-157, TB-500, GHK-Cu & GH Peptides

Injuries are inevitable. Whether you are recovering from a torn tendon, a post-surgical repair, or chronic connective tissue damage that never fully healed, peptides have emerged as one of the most promising tools in the regenerative medicine toolbox. The ultimate healing peptide stack combines four classes of peptides — each targeting a distinct mechanism of repair — to create a synergistic protocol that outperforms any single agent.

This guide breaks down the science, the dosing, and the practical protocol for using BPC-157, TB-500, GHK-Cu, and growth hormone secretagogues together for maximum tissue regeneration.

Why Combine Peptides for Healing?

Single-peptide protocols have real limitations. BPC-157 excels at tendon and gut repair but has modest effects on systemic inflammation. TB-500 promotes widespread actin polymerization and angiogenesis but works more slowly on localized injuries. GHK-Cu remodels collagen and activates repair genes. Growth hormone peptides drive the anabolic environment needed to lay down new tissue.

Together, these peptides address every phase of healing: inflammation modulation, angiogenesis, cell migration, collagen synthesis, and anabolic rebuilding. That is why serious practitioners use all four rather than any single compound in isolation.

BPC-157: The Anchor of Any Healing Stack

Body Protection Compound-157 is a 15-amino-acid peptide fragment derived from a protein found in gastric juice. Its healing credentials are among the most documented of any research peptide.

BPC-157 accelerates tendon-to-bone healing, reduces inflammation, upregulates growth hormone receptors in injured tissue, and promotes angiogenesis — the formation of new blood vessels that supply nutrients to healing tissue. Human and animal studies show effects on muscle tears, ligament injuries, bone fractures, and gastrointestinal damage.

Standard healing dose: 250–500 mcg per day, administered subcutaneously near the injury site or systemically. Some protocols split this into two 200–250 mcg injections. Oral BPC-157 (arginate form) at 500–1,000 mcg daily is an alternative for gut-related healing or those who prefer non-injectable administration.

Cycle length: 4–12 weeks depending on injury severity. BPC-157 does not require cycling in most research contexts, but 8–12 week protocols followed by a 4-week break are common in practice.

For a deeper look at this peptide alone, see the guide on BPC-157 for injury recovery.

TB-500: Systemic Repair and Angiogenesis

Thymosin Beta-500 (TB-500) is a synthetic version of the naturally occurring Thymosin Beta-4 peptide. Its primary mechanism involves upregulating actin, a protein critical for cell motility and tissue repair. When cells can migrate efficiently into damaged areas, healing accelerates dramatically.

TB-500 is particularly valuable for:

• Chronic injuries that BPC-157 alone hasn't resolved
• Systemic inflammation affecting multiple tissue sites
• Cardiac muscle repair (well-documented in animal models)
• Promoting new blood vessel formation in ischemic or poorly vascularized tissue

Standard healing dose: 2–2.5 mg twice weekly for the first 4–6 weeks (loading phase), followed by 2–2.5 mg once weekly as maintenance. TB-500 can be injected subcutaneously or intramuscularly.

The combination of BPC-157 and TB-500 is arguably the most popular healing stack in peptide research circles, and for good reason — their mechanisms are complementary rather than redundant. See the dedicated TB-500 peptide guide for full details.

GHK-Cu: Collagen Remodeling and Gene Activation

Copper peptide GHK-Cu (glycine-histidine-lysine bound to copper) is a naturally occurring tripeptide that declines significantly with age. At its peak in young adults, GHK-Cu concentrations in plasma hover around 200 ng/mL; by age 60 that figure drops to roughly 80 ng/mL — a decline that corresponds closely to the deterioration in wound healing seen in older individuals.

GHK-Cu activates over 4,000 genes, including those governing:

• Collagen and elastin synthesis
• Anti-inflammatory signaling
• Antioxidant enzyme production
• Nerve growth factor expression
• Skin and wound repair

In the context of a healing stack, GHK-Cu provides the collagen-remodeling layer that BPC-157 and TB-500 alone don't fully cover. Scar tissue formed without adequate GHK-Cu signaling tends to be fibrous and disorganized. With GHK-Cu present, collagen lays down in more functional patterns.

Dosing options: Injectable GHK-Cu at 1–2 mg per day subcutaneously is the most potent approach. Topical GHK-Cu creams (1–2% concentration) applied directly over healing tissue offer a non-injectable alternative with good local penetration.

Growth Hormone Secretagogues: The Anabolic Foundation

Tissue can only rebuild as fast as the anabolic environment allows. Growth hormone (GH) and its downstream mediator IGF-1 are essential for protein synthesis, satellite cell activation, and the final assembly of repaired tissue. Rather than using exogenous GH (which carries significant regulatory and safety considerations), GH secretagogues stimulate the pituitary to release endogenous GH in natural pulses.

The most evidence-supported options for a healing context:

Ipamorelin (200–300 mcg, 3x daily or before sleep): The cleanest GH secretagogue with minimal cortisol or prolactin side effects. Pairs well with CJC-1295 (without DAC) for amplified GH pulse height.

CJC-1295 (without DAC, 100–200 mcg per injection): A GHRH analog that primes the pituitary to respond more robustly to ipamorelin's ghrelin-mimetic signal. The combination produces GH pulses 2–10 times larger than ipamorelin alone.

Sermorelin (200–500 mcg before sleep): A shorter-acting GHRH analog. Good option for those new to GH peptides or on a tighter budget. See the sermorelin guide for details.

For the healing stack, CJC-1295 + ipamorelin before sleep is the gold standard — it capitalizes on the natural GH surge that occurs during early sleep cycles.

The Complete Ultimate Healing Protocol

Phase 1 — Acute healing (Weeks 1–6):

• BPC-157: 500 mcg/day subcutaneously (split AM/PM)
• TB-500: 2.5 mg twice weekly (loading phase)
• GHK-Cu: 1 mg/day subcutaneously or topically over injury
• CJC-1295 (no DAC) + Ipamorelin: 200 mcg of each before sleep

Phase 2 — Consolidation (Weeks 7–12):

• BPC-157: 250 mcg/day (maintenance or as needed)
• TB-500: 2 mg once weekly
• GHK-Cu: continue at same dose
• CJC-1295 + Ipamorelin: continue before sleep

Off cycle (Weeks 13–16): Allow 4 weeks before beginning another full cycle. Continue GH secretagogues if desired — they have well-established long-term safety profiles.

Supporting the Stack: Nutrition and Physical Therapy

No peptide stack works optimally in a nutritional vacuum. Support this protocol with:

• Protein: 1.6–2.2 g/kg body weight daily to supply amino acids for collagen synthesis
• Vitamin C: 1–2 g/day — essential cofactor for hydroxylation of proline and lysine in collagen
• Zinc: 15–30 mg/day supports wound healing and immune function
• Omega-3s: 2–4 g EPA+DHA daily reduces pro-inflammatory eicosanoid production

Physical therapy and progressive loading of healing tissue remain non-negotiable. Peptides accelerate the biological process; mechanical loading signals tell the tissue how to organize. The two must work together.

Safety and Sourcing Considerations

The peptides in this stack are research compounds not approved by the FDA for human therapeutic use. Quality control varies significantly across vendors. Prioritize suppliers that provide third-party COAs (certificates of analysis) with HPLC purity data above 98%. Contaminated or misdosed peptides are the most common source of adverse effects.

Common side effects at standard doses are mild: injection site redness, transient fatigue with TB-500 loading doses, and occasional water retention with GH secretagogues. Serious adverse events in research settings are rare when pharmaceutical-grade compounds are used.

For a broader safety overview, see are peptides safe.

Frequently Asked Questions

Q: Can I run this stack alongside standard medical treatment after surgery? Peptide research in post-surgical contexts is promising, but disclose all compound use to your surgeon. Some surgeons are familiar with BPC-157 and supportive; others are not. Do not substitute peptides for prescribed post-operative care.

Q: How quickly will I notice results with this stack? BPC-157 effects on pain and inflammation are often noticeable within 1–2 weeks. Structural tissue repair visible on imaging or confirmed by reduced symptoms typically requires 4–8 weeks of consistent use. TB-500's systemic effects accumulate gradually over the loading phase.

Q: Is the oral form of BPC-157 as effective as injectable for injury healing? For localized musculoskeletal injuries, injectable BPC-157 has stronger evidence for direct tissue repair. Oral BPC-157 (arginate form) reaches systemic circulation and appears effective for gut repair and may have systemic anti-inflammatory benefits, but injectable administration near the injury site generally produces more potent local effects.

Q: Do GH secretagogues interfere with the other peptides in this stack? No known negative interactions exist between ipamorelin/CJC-1295 and BPC-157, TB-500, or GHK-Cu. They operate through distinct receptor pathways. Timing injections to avoid the same site on the same day is the main practical consideration.

Q: What is the minimum effective version of this stack if I can't afford all four components? BPC-157 alone is the highest-priority single peptide for most acute injuries. If budget allows a second agent, add TB-500 for its synergistic systemic effects. GHK-Cu topically is relatively affordable. See the minimalist peptide stack for a streamlined approach.